相似文献
1
Risk factors for HIV-1 seroconversion among injection drug users: a case-control study.
Am J Public Health. 1995 Nov;85(11):1538-42. doi: 10.2105/ajph.85.11.1538.
2
Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users.
Am J Epidemiol. 1993 Apr 15;137(8):892-8. doi: 10.1093/oxfordjournals.aje.a116750.
3
Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
Am J Epidemiol. 1992 Feb 1;135(3):225-33. doi: 10.1093/oxfordjournals.aje.a116275.
4
The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.
Am J Epidemiol. 1992 Jul 15;136(2):236-43. doi: 10.1093/oxfordjournals.aje.a116489.
5
A case-control study of HIV infection among incarcerated female drug users: impact of sharing needles and having drug-using sexual partners.
J Formos Med Assoc. 2011 Jul;110(7):446-53. doi: 10.1016/S0929-6646(11)60066-1.
6
HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland.
Epidemiology. 1991 Nov;2(6):444-6. doi: 10.1097/00001648-199111000-00010.
7
AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok.
Am J Public Health. 1994 Mar;84(3):452-5. doi: 10.2105/ajph.84.3.452.
8
HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
Int J STD AIDS. 1998 Apr;9(4):214-8. doi: 10.1258/0956462981922061.
9
Behavioral characteristics of seroconverted intravenous drug users.
Int J Addict. 1992 Dec;27(12):1413-21. doi: 10.3109/10826089209047359.
10
Weight loss associated with HIV seroconversion among injection-drug users.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):514-8. doi: 10.1097/00042560-199608150-00012.
引用本文的文献
1
Disparities of COVID-19 and HIV Occurrence Based on Neighborhood Infection Incidence in Philadelphia, Pennsylvania.
Am J Public Health. 2022 Mar;112(3):408-416. doi: 10.2105/AJPH.2021.306538.
2
A review of network simulation models of hepatitis C virus and HIV among people who inject drugs.
Int J Drug Policy. 2021 Feb;88:102580. doi: 10.1016/j.drugpo.2019.10.006. Epub 2019 Nov 15.
3
Barriers to practicing risk reduction strategies among people who inject drugs.
Addict Res Theory. 2016;24(1):62-68. doi: 10.3109/16066359.2015.1068301. Epub 2015 Jul 21.
4
A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania.
PLoS One. 2016 Feb 5;11(2):e0148598. doi: 10.1371/journal.pone.0148598. eCollection 2016.
5
Cross sectional study of factors associated to self-reported blood-borne infections among drug users.
BMC Public Health. 2015 Nov 13;15:1122. doi: 10.1186/s12889-015-2442-6.
6
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.
BMJ. 2012 Oct 3;345:e5945. doi: 10.1136/bmj.e5945.
7
Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users.
Subst Use Misuse. 2013 Jan;48(1-2):54-64. doi: 10.3109/10826084.2012.722159. Epub 2012 Sep 27.
8
Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trial.
J Subst Abuse Treat. 2012 Oct;43(3):313-21. doi: 10.1016/j.jsat.2012.01.003. Epub 2012 Feb 14.
9
Suburban Poverty: Barriers to Services and Injury Prevention among Marginalized Women who Use Methamphetamine.
West J Emerg Med. 2011 Jul;12(3):284-92.
10
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.
J Acquir Immune Defic Syndr. 2010 Sep;55(1):65-72. doi: 10.1097/QAI.0b013e3181d916db.
本文引用的文献
1
Geographical variations in the prevalence of HIV infection among drug users receiving ambulatory treatment in Spain.
Int J Epidemiol. 1993 Apr;22(2):306-14. doi: 10.1093/ije/22.2.306.
2
Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users.
Am J Epidemiol. 1993 Apr 15;137(8):892-8. doi: 10.1093/oxfordjournals.aje.a116750.
3
Determinants of HIV-1 infection in intravenous drug users in Valencia, Spain, 1987-1991.
Int J Epidemiol. 1993 Jun;22(3):537-42. doi: 10.1093/ije/22.3.537.
4
Drug-related HIV risk behaviors and cocaine preference among injection drug users in Los Angeles.
J Drug Educ. 1993;23(3):259-72. doi: 10.2190/GP3B-4KUD-T0UP-Y9FK.
5
Cross-validation in survival analysis.
Stat Med. 1993 Dec 30;12(24):2305-14. doi: 10.1002/sim.4780122407.
6
HIV seroconversion studies among intravenous drug users.
AIDS. 1994 Feb;8(2):263-5. doi: 10.1097/00002030-199402000-00016.
7
HIV seroconversion in intravenous drug users in San Francisco, 1985-1990.
AIDS. 1994 Feb;8(2):223-31. doi: 10.1097/00002030-199402000-00010.
8
Seroconversion in patients attending sexually transmitted disease clinics.
AIDS. 1994 Mar;8(3):351-5. doi: 10.1097/00002030-199403000-00009.
9
Attitudes toward narcotic addiction.
J Nerv Ment Dis. 1987 Nov;175(11):653-60. doi: 10.1097/00005053-198711000-00002.
10
Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.
Am J Public Health. 1987 Feb;77(2):169-72. doi: 10.2105/ajph.77.2.169.
Zotero 插件